Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon-based PCIA for Pain Management After Laparoscopic Surgery
NCT07246785Phase 4Terminated
- Sponsor
- Peking University First Hospital
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hsk21542 in Visceral pain, sponsored by Peking University First Hospital. Started Dec 2025; status: terminated.
02
Drugs
hsk21542
03
Conditions
Visceral pain
Beyond the preview
Go deeper on NCT07246785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246785.